Lactobacillus helveticus VPro 13 and Reduced Upper Respiratory Infections

• Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial.

  • 2016-07
  • RCT · n = 39
  • Applied Physiology, Nutrition, and Metabolism 41(7)
  • • D. Michaličková
    • R. Minić
    • N. Dikić
    • M. Andjelkovic
    • Marija Kostic-Vucicevic
    • Tamara Stojmenovic
    • Ivan Nikolić
    • B. Djordjevic

  • PubMed: 27363733
  • DOI: 10.1139/apnm-2015-0541

  10 Insights on

  • Reduced Upper Respiratory Infections

  • High evidence

  Lafti L10 significantly shortened the URTI episode duration (7.25 ± 2.90 vs. 10.64 ± 4.67 days, p = 0.047)

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes